Back to ACAD
SOUTHERN CAPITAL ADVISORS, LLC → ACAD
SOUTHERN CAPITAL ADVISORS, LLC ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
5
Latest value
$671K
Q3 2026
Peak value
$686K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $638K |
| Q4 2025 | $671K |
| Q1 2026 | $649K |
| Q2 2026 | $686K |
| Q3 2026 | $671K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $671K | 3.8K | — | — |
| Q2 2026 | $686K | 3.9K | — | — |
| Q1 2026 | $649K | 4.0K | — | — |
| Q4 2025 | $671K | 3.7K | — | — |
| Q3 2025 | $638K | 3.6K | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M
$211.3M
$202.4M